.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Mary's Medicinals is stocked at 768 licensed dispensaries across California, Michigan, and 9 other states, 287 of them in California, with the deepest coverage in Los Angeles, San Diego, Sacramento, La Mesa, and Santa Ana. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, Mary's Medicinals concentrated 74.59% of sales in Topical, while Tincture & Sublingual accounted for 25.41%, with Topical down 9.84% year over year and 9.12% month over month versus Tincture & Sublingual up 25.86% year over year but down 9.17% month over month. Despite an overall brand sales change of -2.97% year over year and an average price rising 5.82% year over year to $29.04, Topical’s average price of 29.58 outpaced Tincture & Sublingual at 27.55, anchoring mix but amplifying exposure to Topical’s double decline; this pattern implies the brand is relying on a shrinking category engine while the smaller Tincture & Sublingual line provides the only year-over-year growth offset.
Positioning-wise, ranking 1 in Topical in Missouri contrasts with a brand-level 24‑month sales decline of 29.11% and a current Topical share of 74.59%, indicating leadership concentrated where category headwinds are steepest and where month-over-month pressure of -9.12% is pulling mix down. With Tincture & Sublingual delivering 25.86% year-over-year growth yet representing just 25.41% of mix alongside a month-over-month dip of -9.17%, the implication is that expanding the faster-growing, lower‑priced format is the most direct lever to reduce volatility from Topical’s dual declines and to diversify revenue away from a single-category rank position.
Competitive Landscape
Mary's Medicinals holds rank #2 in California Topical for September 2026, unchanged year over year from #2, with stability also across the last three months at #2; this flat rank position against a peak rank of #2 in September 2026 indicates a ceiling effect even as category dynamics shift. The current #1, Papa & Barkley, stayed at #1 while posting a -1.5% year-over-year sales change, whereas #3 Buddies maintained #3 with +15.9% sales growth, and Sweet ReLeaf (CA) climbed from #5 to #4 with +30.2%; in contrast, Carter's Aromatherapy Designs (C.A.D.) slipped from #4 to #5 despite +20.5% sales growth, reinforcing that share reallocation rather than uniform category expansion is driving movement. The pattern implies Mary's Medicinals must convert #1 shopper gains or defend against #3 momentum, because holding #2 while the leader contracts by -1.5% and the chasers post +15.9% to +30.2% suggests share pressure is building even without a rank drop.
Notable Products
The Remedy Energy Tincture (1000mg THC, 13.5ml) posted the steepest movement in September 2026 with a -19.9% month-over-month drop while sliding to rank 9, and the CBD/THC/CBN 2:3:1 Formula Transdermal Patch (10mg CBD, 15mg THC, 5mg CBN) fell further at -39.3% to rank 10, indicating volatility concentrated at the lower end of the top ten. At the top, CBD/THC 1:1 Vanilla Lavender Transdermal Relax Cream (1000mg CBD, 1000mg THC, 2oz, 59.1ml) rose 12.7% to hold rank 1 and CBD/THC 1:1 Large Colling Action Relief Muscle Freeze (1000mg CBD, 1000mg THC, 3oz) gained 9.4% at rank 5, while CBD/THC 1:1 Relief Transdermal Compound Balm (500mg CBD, 500mg THC, 1oz) dipped -3.6% at rank 2. Four of the top ten are Topical SKUs, and their mixed +12.7% and +9.4% gains alongside a -6.7% decline at rank 7 suggest share is consolidating around two flagship creams even as secondary items soften; this implies Mary's Medicinals is skewing toward higher-concentration transdermal formats as the commercial core.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
